Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms

NCT06185985 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: SPN-812

Sponsor

Supernus Pharmaceuticals, Inc.